[Form 4] Live Oak Bancshares, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Live Oak Bancshares insider transaction summary: Walter J. Phifer, Chief Financial Officer, reported a disposal of 5,743 shares of the company's voting common stock on 08/18/2025. On the same date he was granted 14,581 restricted stock units (RSUs) that convert one-for-one into voting common stock and vest in five equal annual installments beginning on August 18, 2026, subject to continued service.
The filing also lists several previously granted RSU tranches with staggered vesting dates and an employee stock option exercisable for 6,160 shares (exercise price $13.59) that vested in multiple installments through February 16, 2023. All reported equity holdings are held directly by the reporting person.
Positive
- 14,581 RSUs granted on 08/18/2025 that convert one-for-one into voting common stock, supporting long-term retention
- Employee stock option for 6,160 shares is exercisable (exercise price $13.59) and fully vested through 2023
Negative
- Disposition of 5,743 voting shares reported on 08/18/2025
- No cash proceeds or sale price disclosed for the disposed shares in this filing
Insights
TL;DR: Routine insider equity activity: a sale plus a new RSU grant with standard multi-year vesting tied to continued service.
The disposal of 5,743 voting shares is reported alongside a contemporaneous grant of 14,581 RSUs that vest over five years beginning August 18, 2026. This structure is consistent with retention-focused compensation practices and aligns executive incentives with long-term service. The filing shows the CFO holds multiple RSU tranches with staggered vesting and an outstanding employee stock option for 6,160 shares at a $13.59 strike that fully vested through 2023. There are no indications of indirect holdings or third-party arrangements in the disclosure.
TL;DR: Grant and prior vesting activity are typical for executive compensation; transaction appears administrative rather than transformative.
The 14,581 RSU grant and prior tranches create multi-year vesting schedules that will deliver shares contingent on continued service. The option described has completed its vesting schedule through 2023 and remains exercisable for 6,160 shares at a $13.59 exercise price. The reported disposal of 5,743 shares reduces immediate share ownership but is offset by forthcoming RSU issuances. No cash compensation amounts or proceeds from the disposition are disclosed in this Form 4.